Skip to main content
SpringerLink
Log in

Alemtuzumab

Allergic inflammatory syndrome and eosinophilc acalculous cholecystitis: 2 case reports

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Fontes-Villalba A, et al. Alemtuzumab induced allergic inflammatory syndrome (alias) with eosinophilic acalculous cholecystitis: A report of two cases. Journal of Neurology, Neurosurgery and Psychiatry 89: e30 abstr. 073, No. 6, Jun 2018. Available from: URL: http://doi.org/10.1136/jnnp-2018-ANZAN.72 [abstract] - Australia

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alemtuzumab. Reactions Weekly 1710, 20 (2018). https://doi.org/10.1007/s40278-018-48694-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-48694-x

Search

Navigation